Aprogen Biologics, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical and Bio business divisions. The Pharmaceutical business division provides synthetic pharmaceuticals such as circulatory system drugs, central nervous system drugs, digestive system drugs, and antibiotics. The Bio business division manufactures biopharmaceuticals. The company was founded on December 3, 1960 and is headquartered in Seoul, South Korea.